Source: Annual Congress 2010 - Pulmonary vascular diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Fedorowicz, T. Skorka, A. Jakubowski, M. Walczak, J. Szymura-Oleksiak, S. Chlopicki (Krakow, Poland). Progression of endothelial dysfunction in relationship with development of pathomorphological changes in monocrotalin-induced model pulmonary hypertension in rats. Eur Respir J 2010; 36: Suppl. 54, 4491

Member's Comments

No comment yet.

Related content which might interest you: Potential contribution of precursor cells to vascular remodeling in the AdTGF-β1 model of lung fibrosis and pulmonary hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 173s Year: 2001 Vascular sexual dimorphism and pulmonary hypertension in a rat chronic hypoxia model. Source: International Congress 2017 – Experimental PH Year: 2017 Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2015; 46: 431-443 Year: 2015 Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021 Year: 2021 Inflammatory changes in a murine model of monocrotaline-induced pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 365s Year: 2005 Loss of Bmp9 does not lead to spontaneous pulmonary hypertension, but attenuates vascular remodeling in experimental models Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007 Primary pulmonary hypertension and endothelial dysfunction Source: Eur Respir J 2003; 22: Suppl. 45, 583s Year: 2003 Renal dysfunction correlates with impaired hemodynamics and unfavorable outcome in pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 Pulmonary hypertension: the science behind the disease spectrum Source: Eur Respir Rev 2012; 21: 19-26 Year: 2012 Altered control of cerebral circulation in chronic obstructive pulmonary disease: an early sign of cardiovascular autonomic dysfunction Source: Annual Congress 2008 - COPD Year: 2008 In a model of genetic pulmonary hypertension, VIP attenuates pulmonary vascular remodeling and right ventricular hypertrophy Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension Year: 2007 Novel hypoxia system to assess endothelial dysfunction in chronic thromboembolic pulmonary hypertension (CTEPH) Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction Source: Eur Respir J 2014; 44: 160-168 Year: 2014 Effects of hypoxia-induced chronic changes in pulmonary haemodynamics on the lung function and responsiveness in rats Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans Year: 2009 First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1701694; 10.1183/13993003.01694-2017 Year: 2018 Two rat models of hemolysis-induced pulmonary hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Association of renal dysfunction with hemodynamics and survival in pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010